MarketFriction

Maestros Mediline Systems Ltd

BSE 501209
Market cap₹2,976 Cr.
Not trading

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Jun 2013Sep 2013Dec 2013Jun 2014Sep 2014
Sales3.441.970.261.091.07
Expenses4.410.050.360.581.76
Operating Profit-0.971.92-0.100.51-0.69
OPM %-28.20%97.46%-38.46%46.79%-64.49%
Other Income0.000.000.020.000.00
Interest0.180.010.000.000.01
Depreciation0.480.510.480.180.19
Profit before tax-1.631.40-0.560.33-0.89
Tax %0.00%0.00%0.00%0.00%0.00%
Net Profit-1.631.40-0.570.32-0.89
EPS in Rs-3.703.18-1.300.73-2.02
Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Sales33.8129.2330.0541.7842.4021.757.024.230.56
Expenses30.2825.6626.0633.4834.7931.9320.4625.742.99
Operating Profit3.533.573.998.307.61-10.18-13.44-21.51-2.43
OPM %10.44%12.21%13.28%19.87%17.95%-46.80%-191.45%-508.51%-433.93%
Other Income0.270.590.940.800.230.76-0.880.040.14
Interest1.591.842.392.954.045.380.370.030.02
Depreciation1.271.261.762.371.862.061.000.790.70
Profit before tax0.941.060.783.781.94-16.86-15.69-22.29-3.01
Tax %44.68%75.47%23.08%2.91%-7.73%-7.41%0.00%0.00%0.00%
Net Profit0.520.260.603.672.08-15.61-15.69-22.29-3.00
EPS in Rs0.591.368.344.73-35.48-35.66-50.66-6.82
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%-58%-70%-87%
Compounded Profit Growth%%22%87%
Stock Price CAGR%%%%
Return on Equity%%%%
Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Equity Capital4.554.424.374.374.374.374.374.374.37
Reserves30.8930.7731.2334.9713.15-2.56-18.39-41.46-44.46
Borrowings4.397.797.5011.7238.9649.6851.0654.1054.37
Other Liabilities18.6023.5826.0024.3921.2522.4320.165.917.79
Total Liabilities58.4366.5669.1075.4577.7373.9257.2022.9222.07
Fixed Assets23.1728.0428.1931.1415.6215.2813.4511.8911.19
CWIP0.180.360.000.007.400.000.000.000.00
Investments3.890.310.310.810.000.000.000.000.00
Other Assets31.1937.8540.6043.5054.7158.6443.7511.0310.88
Total Assets58.4366.5669.1075.4577.7373.9257.2022.9222.07
Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Cash from Operating Activity12.767.283.242.84-7.50-6.77-0.45-0.270.09
Cash from Investing Activity-4.82-2.58-1.55-5.98-14.891.080.94-0.380.05
Cash from Financing Activity-7.480.98-2.881.2823.802.16-0.26-0.140.04
Net Cash Flow0.465.68-1.19-1.861.41-3.530.22-0.790.18
Free Cash Flow12.787.283.242.86-22.48-6.77-0.45-0.270.09
CFO/OP361%204%81%34%-99%66%3%1%-4%
Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Debtor Days151.89138.36152.19127.11214.18393.031,302.46225.211,251.43
Inventory Days159.11235.55273.09240.68262.43241.1766.5440.1669.30
Days Payable114.78180.48239.65153.77208.96179.85256.98128.951,686.39
Cash Conversion Cycle196.22193.42185.64214.03267.65454.351,112.02136.43-365.66
Working Capital Days138.29120.38138.83162.84259.03579.301,132.44319.271,003.75
ROCE %7.00%7.37%14.32%11.12%-21.27%-32.62%-82.37%-19.11%
Jun 2016Sep 2016
Promoters49.64%49.64%
DIIs1.49%1.49%
Public48.87%48.87%
No. of Shareholders1,2171,217

Fundamentals

Market Cap₹ 2,976 Cr.
Current Price₹ 10.4
Book Value₹ -91.1
ROCE-19.1 %
ROE%
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-87%
Compounded Profit Growth (TTM)87%
Consolidated figures.
Valuation
P/B, 3-year average2.15x
P/E, 5-year average5.00x
P/B, 5-year average1.51x
Profitability
Operating margin (excl. other income)-508.51%
Operating margin (incl. other income)-507.56%
EBITDA margin-507.56%
Pre-tax margin-526.95%
Net profit margin-526.95%
ROE87.22%
ROCE-82.37%
ROA-55.64%
ROE, 3-year average60.91%
ROCE, 3-year average-46.08%
ROA, 3-year average-33.39%
ROE, 5-year average39.97%
ROCE, 5-year average-22.57%
ROA, 5-year average-18.47%
ROIC (approx.)-135.07%
Other income / net worth-0.11%
Growth
Sales growth (latest year)-39.74%
Sales CAGR, 3 years-53.62%
Sales CAGR, 5 years-32.44%
Per share
EPS (TTM)Rs -0.08
EPS (latest year)Rs -50.97
EPS, 3-year averageRs -40.85
EPS, 5-year averageRs -21.88
Book value per shareRs -0.13
Sales per shareRs 0.01
Cash flow per shareRs -0.00
Free cash flow per shareRs 0.00
Efficiency
Asset turnover0.18x
Fixed asset turnover0.36x
Inventory turnover9.28x
Inventory days39 days
Debtor days225 days
Debtors turnover1.62x
Creditor days1686 days
Cash conversion cycle-366 days
Working capital days1004 days
Leverage
Total debtRs 54 Cr
Cash and bankRs 1 Cr
Net debtRs 54 Cr
Debt to equity-1.46x
Interest coverage-742.00x
Owners' fund to total sources-161.82%
Debt to assets236.04%
Cash flow
Cash from Operating Activity (latest year)Rs -0 Cr
Cash from Investing Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs -0 Cr
Net Cash Flow (latest year)Rs -1 Cr
Free cash flow (latest year)Rs 0 Cr
FCFE (approx.: FCF + change in debt)Rs 3 Cr
Statement figures
Net sales (TTM)Rs 4 Cr
Net sales (latest year)Rs 4 Cr
Operating profit excl. other income (latest year)Rs -22 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs -21 Cr
PBDT (TTM)Rs -22 Cr
Profit before tax (TTM)Rs -22 Cr
Net profit (TTM)Rs -22 Cr
Net profit (latest year)Rs -22 Cr
Depreciation (TTM)Rs 1 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 5 Cr
Total expenditure (latest year)Rs 26 Cr
Total income (latest year)Rs 4 Cr
Share capitalRs 4 Cr
ReservesRs -41 Cr
Shareholders' fundsRs -37 Cr
Total assetsRs 23 Cr
Net blockRs 12 Cr
ReceivablesRs 3 Cr
InventoryRs 1 Cr
Other liabilitiesRs 6 Cr
Shares outstanding (crore)285.04
Ownership
Promoter holding49.64%
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.

Red flags

F-score 3 of 8
seriousNegative equity Shareholders' equity is negative
lookRepeated losses Net loss in each of the last two years
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Sep 2014
Sales ₹1 Cr -68.9% vs Jun 2013. Net loss ₹1 Cr.

Activity

Compare
No listed peers in this industry.
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Maestros Mediline Systems Ltd?

Maestros Mediline Systems Ltd (501209) has a market capitalisation of Rs 2,976 Cr. at the close.

What were Maestros Mediline Systems Ltd's latest quarterly results?

In the Sep 2014 quarter, Maestros Mediline Systems Ltd sales was Rs 1 Cr (-68.9% vs Jun 2013) with a net loss of Rs 1 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03